F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market

Health
By BY CHRISTINA JEWETT from NYT Health https://ift.tt/KqyckYT
via IFTTT Babies and Infants, Pregnancy and Childbirth, Premature Babies, Drugs (Pharmaceuticals), Regulation and Deregulation of Industry The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

Comments

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

The Jarring Contradiction at the Heart of Kennedy’s Agenda